Emotional Resilience

Emotional Resilience: A Nutrition and Natural-Health Reference

1. Definition and Conceptual Framing

Resilience is a human capacity to adapt swiftly and successfully to stressful or traumatic events and manage to revert to a positive state. In the psychological sciences, the construct is simultaneously understood as a stable personality trait and as a dynamic, state-like capacity that can fluctuate with circumstances. Psychological resilience, a critical counteracting factor of psychopathology, is defined as the ability to rebound from a difficult situation. There are multiple conceptualizations of resilience in the field of resilience research; for instance, researchers have classified resilience into two separate concepts: state resilience and trait resilience.

Emotional resilience, specifically, refers to an organism's ability to respond to stressful situations in an adaptive manner, providing a neurobiological buffer against the negative effects of stress and leading to decreased susceptibility to psychiatric illnesses. At the level of individual emotional experience, psychological resilience consists of social resources and protective factors for individuals against negative effects, and can influence the process of meta-cognition of individuals in response to emotion feelings. Critically, individuals with high or low resilience may produce various emotional experiences when facing the same events.

Resilience is a psychobiological factor that determines an individual's response to adverse life events. This framing positions emotional resilience not as the mere absence of distress, but as an active, biologically grounded capacity. It is fundamental for growth of positive psychology, which deals with satisfaction, adaptability, contentment, and optimism in people's life.

Allostatic theory provides one influential explanatory framework. Allostatic load refers to changes in biological functioning from cumulative effects of chronic stress. Resilience is the capacity to minimize allostatic load. Under this model, individuals with greater emotional resilience are those whose biological systems recover more efficiently from stress-induced perturbations, thereby accumulating less wear over time.

2. How Emotional Resilience Presents: Observable Characteristics

Emotional resilience does not present as a single observable symptom but rather as a cluster of functional capacities. High resilience is typically reflected in rapid emotional recovery after adversity, maintenance of stable mood under chronic pressure, cognitive flexibility, and sustained engagement with social and occupational life despite difficulty. Conversely, diminished resilience tends to present as protracted emotional reactivity, poor recovery from stressors, impaired emotion regulation, and heightened vulnerability to mood disorders.

Clarifying individual differences that predict resilience or vulnerability to emotional distress is crucial for identifying etiological factors contributing to affective disturbances and for promoting emotional well-being. From a neurobiological perspective, researchers have conceptualized a closely related dimension: not only the neural responses during the presentation of stressful stimuli or rewarding information are important, but also the neural recovery after these events — in particular longer recovery after stress and shorter recovery after reward — may play a role. This has been conceptualized as emotional inertia and has been brought into relationship with difficulties in emotion regulation.

3. Body Systems Involved

3.1 The Hypothalamic–Pituitary–Adrenal (HPA) Axis

The autonomic nervous system and the hypothalamic-pituitary-adrenal (HPA) axis play a key role in orchestrating the body's reaction to threats. Physiological responses to stress manifest through two main pathways: the activation of the HPA axis, which releases corticotropin-releasing factor (CRF) from the paraventricular nucleus (PVN) of the hypothalamus in the presence of stressor stimuli and activates the anterior pituitary gland to liberate adrenocorticotrophic hormone (ACTH), which travels throughout the bloodstream to the suprarenal gland that releases cortisol, and the autonomic nervous system.

Far beyond a simple "stress hormone pathway," the HPA axis integrates cognition, emotion, metabolism, immunity, circadian timing, and neuroplasticity. The HPA axis interacts closely with limbic circuits involved in fear, reward, and emotional memory. Balanced HPA activity supports emotional flexibility and stress tolerance, whereas prolonged hyperactivation is strongly associated with anxiety, depression, and mood disorders.

Exposure to chronic stress leads to excessive cortisol exposure that increases vulnerability to a variety of physical diseases — hypertension, immunosuppression, cardiovascular disease — and mental disorders such as anxiety, PTSD, and depressive disorders. The HPA axis is therefore both a key mediator of resilience when well-regulated and a source of vulnerability when chronically dysregulated.

3.2 Brain Circuits and Neuroplasticity

Resilience is a neurobiological construct with significant neurobehavioral and emotional features which plays an important role in deconstructing mechanisms of biopsychosocial functioning. The neuroscience of resilience is beginning to uncover the circuits and molecules that protect against stress-related neuropsychiatric diseases.

Regions in the emotional network were reported the most in relevant neuroimaging studies. The involvement of regions like the amygdala and orbitofrontal cortex indicated the relationships between emotional processing and resilience. The prefrontal cortex (PFC) is also centrally implicated: the PFC has major projections to the amygdala, an important structure associated with emotional processing.

The hippocampus is important in mediating responses to stress. Both mineralocorticoid and glucocorticoid receptors are vastly expressed in the hippocampus, making it a region highly responsive to activation of the HPA axis. Brain-derived neurotrophic factor (BDNF), a key neurotrophin, links neuroplasticity to emotional resilience. BDNF is vital to the survival, growth, and maintenance of neurons in key brain circuits involved in emotional and cognitive function. Convergent evidence indicates that neuroplastic mechanisms involving BDNF are deleteriously altered in major depressive disorder (MDD) and animal models of stress.

3.3 The Immune System and Neuroinflammation

Research on the neurobiology of resilience focuses on physiological and transcriptional adaptations of specific brain circuits, the role of cellular and humoral factors of the immune system, the gut microbiota, and changes at the interface between the brain and the periphery, including the blood-brain barrier. The immune system affects the CNS, modulating the HPA axis; acutely, stressful experiences enhance levels of circulatory pro-inflammatory cytokines. Chronic low-grade neuroinflammation is increasingly viewed as a mediator of reduced emotional resilience and a contributor to stress-related mood disorders.

3.4 The Gut-Brain Axis

Evidence indicates that gut microbiota modulate neurochemical pathways involving serotonin, dopamine, GABA, and glutamate, as well as immune and endocrine axes. Dysbiosis has been associated with neuropsychiatric disorders such as depression, anxiety, impulsivity, cognitive decline, and addiction. The gut-brain axis thus represents an important peripheral system through which nutrition and microbiome composition may influence central emotional resilience.

3.5 The Glucocorticoid System and Epigenetics

Glucocorticoids (GCs) are important regulators of basal and stress-related homeostasis that influence a wide array of genes in almost every organ and tissue. GCs are ideally situated to either promote or prevent adaptation to stress. Understanding of the psychopathology of mental disorders is evolving, particularly with the availability of newer insight from the fields of genetics, epigenetics, and social and environmental pathology. It is now becoming clear how biological factors contribute to development of illness in the face of psychosocial factors.

4. Contributing and Associated Factors

4.1 Early-Life Experience and Stress Inoculation

If pups experience maternal deprivation for a long period, they show higher susceptibility to subsequent stressors in adult life, HPA axis hyperactivity, and altered glucocorticoid responses. However, if stress exposure is less severe, it can have pro-resilient effects — a process termed stress-inoculation. This dose-dependent relationship between early adversity and later resilience has been documented across species.

4.2 Neurobiological Biomarkers

Decades of research have investigated the importance of the HPA axis in psychosocial stress and indeed led to potential clinically applicable biomarkers — for example, neuropeptide Y (NPY) and dehydroepiandrosterone (DHEA). Both NPY and DHEA have been explored as proxies for resilience capacity, though their clinical utility remains under active investigation.

4.3 Positive Emotions and the Cumulative Effect

The impact of positive emotions is cumulative; repeated positive emotional experiences over time prime the system for optimal response to negative stimuli by expanding physical, psychological, intellectual, and social resources. Prosocial behaviors, meaning-making, humor, and exercise can foster and support resilience and reduce the intensity and duration of stress responsivity, and such positive activities are associated with reduced HPA axis reactivity.

4.4 Sleep Disturbance

Poor sleep quality, sleep deprivation, and sleep disorders can all lead to HPA axis dysregulation, characterized by elevated cortisol levels and altered stress responses. Conversely, adequate sleep, particularly deep sleep, supports HPA axis regulation and cortisol suppression. Sleep disorders may represent a prodromic factor for mental and brain health issues, being associated with cognitive and affective disorders, as well as neurodegenerative conditions in general.

4.5 Chronic Psychological Stress and Lifestyle

HPA axis dysfunction — a major driver of diminished resilience — is influenced by a complex interplay of internal and external stressors, including chronic psychological stress, dietary imbalances, disrupted circadian rhythms, and environmental exposures.

5. Nutrients Studied in Relation to Emotional Resilience

5.1 Omega-3 Polyunsaturated Fatty Acids (EPA and DHA)

Overview: The omega-3 polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are key dietary components investigated extensively in relation to psychiatric outcomes, owing to the therapeutic potential of their expanding repertoire of potent bioactive derivatives.

Proposed Mechanisms: Despite the different bioactivity between EPA and DHA, there is a robust biological basis supporting their anxiolytic and antidepressant potential, comprising modulation of neuronal membrane properties, receptor expression and neurotransmission, antioxidant, anti-inflammatory and pro-resolving activity, and promotion of neuroplasticity and neuroprotection.

Dietary Pattern Context: Populations adhering to Mediterranean or traditional Japanese diets, which are rich in omega-3s and low in processed seed oils, consistently exhibit lower prevalence of mood disturbances and greater emotional resilience. Reducing the dietary omega-6 to omega-3 ratio to below 5:1 — through increased omega-3 intake and reduced omega-6 consumption — may enhance the effectiveness of antidepressant treatments and improve response to nutritional interventions.

Scientific Evidence — Clinical Studies: Beneficial effects of omega-3 fatty acids have been reported for several psychiatric disorders, particularly for depression. Association studies show a relationship between omega-3 intake and depression risk. Meta-analyses of clinical trials have shown a moderate effect of supplementation on depressive symptoms, but not on normal mood states. In a double-blind, randomized, placebo-controlled study, 71 participants were randomized to receive either omega-3 or placebo for four weeks. Results showed small effects of omega-3 supplementation on aspects of emotional decision-making and on self-reported states of depression and tension.

Evidence Strength: Preclinical and epidemiological studies consistently associate anxious and depressive states with poor omega-3 PUFA status. Correcting the latter by supplementation improves mood profiles. However, meta-analyses of RCTs administering omega-3 PUFAs have produced mixed results. Overall, evidence is moderate and most consistent for EPA-predominant preparations in individuals with elevated inflammatory markers or existing depressive symptoms; evidence for healthy, non-distressed populations is weaker.

5.2 Magnesium

Overview and Proposed Mechanisms: Magnesium status is associated with subjective anxiety, leading to the proposition that magnesium supplementation may attenuate anxiety symptoms. Low serum magnesium concentrations increase the release of stress-associated hormones including catecholamines, adrenocorticotrophic hormone, and cortisol in response to stress, creating a vicious cycle of reduced resistance to stress and further magnesium depletion.

Scientific Evidence — Clinical Studies: The relationship between serum magnesium concentration and stress has been evidenced in a clinical trial reporting an association between low serum magnesium concentrations and greater perceived stress in otherwise healthy women. Other studies have documented a positive effect of magnesium supplementation on symptoms and biomarkers of stress. A 2023 systematic review and meta-analysis including seven randomized clinical trials with a total of 325 individuals found that magnesium supplementation resulted in a significant decline in depression scores (standardized mean difference: −0.919, 95% CI: −1.443 to −0.396, p = 0.001). One included trial showed that a 2-week intervention with 248 mg of elemental magnesium per day can lead to clinical improvement in patients with anxiety and depressive disorders.

Magnesium Combined with Vitamin B6: A randomized clinical trial investigating the combination found that animal and clinical studies suggest complementary effects of magnesium and high-dose pyridoxine (vitamin B6) on stress reduction. This was the first randomized trial evaluating the effects of combined magnesium and vitamin B6 supplementation on stress in a stressed population with low magnesemia using a validated measure of perceived stress.

Evidence Strength: Evidence for magnesium's role in stress and mood is promising but the body of RCT evidence remains limited by small sample sizes and inconsistent methodologies. The findings from randomized clinical trials examining the effect of magnesium supplementation on depression are inconsistent. Further large-scale, well-powered trials are needed.

5.3 B Vitamins

B vitamins, including B6, B9 (folate), and B12, are essential cofactors in the synthesis of neurotransmitters including serotonin, dopamine, and GABA. A combination study using fMRI neuroimaging assessed the effect of a combination product containing magnesium, vitamins B6, B9, B12, Rhodiola rosea, and L-theanine versus placebo on the brain response to stressful thermal stimuli in chronically stressed but otherwise healthy subjects. Impacts on stress-related quality-of-life parameters — including depression, anxiety, sleep, and pain perception — were also explored. This multi-ingredient design, while clinically interesting, precludes attribution of effects to any single B vitamin. The broader evidence base for B vitamins in mood and resilience is anchored predominantly in observational and epidemiological research, with RCTs showing variable results depending on baseline deficiency status.

6. Herbs and Natural Ingredients Studied in Relation to Emotional Resilience

6.1 Ashwagandha (Withania somnifera)

Traditional Use: Withania somnifera (WS), also known as Ashwagandha, is commonly used in Ayurveda and other traditional medicine systems. WS has seen an increase in worldwide usage due to its reputation as an adaptogen. In Ayurvedic classical texts, the root is historically prepared as a powder or decoction and is described as a rasayana — a class of formulations intended to promote vitality, longevity, and resistance to disease. Ayurvedic classical texts, animal studies, and clinical studies describe Ashwagandha as a safe and effective adaptogen.

Active Constituents: Ashwagandha contains a range of constituents like withanolides, sitoindosides, and other alkaloids that are pharmacologically and medicinally important.

Scientific Evidence — Clinical Studies: In a single-center, prospective, double-blind, randomized, placebo-controlled trial, 64 subjects with a history of chronic stress were enrolled. These included a measurement of serum cortisol and assessment of scores on standard stress-assessment questionnaires. The findings suggest that high-concentration full-spectrum Ashwagandha root extract improves an individual's resistance towards stress and thereby improves self-assessed quality of life.

In a separate eight-week, double-blind, placebo-controlled dose-ranging study, a significant reduction in Perceived Stress Scale (PSS) scores was observed with Ashwagandha 250 mg/day (P < 0.05) and 600 mg/day (P < 0.001). Serum cortisol levels reduced with both doses. Compared to the placebo group, participants receiving Ashwagandha had significant improvement in sleep quality.

A 2025 systematic review and meta-analysis of RCTs concluded that Ashwagandha supplementation is safe and effective in reducing stress and anxiety in adult patients, resulting in a statistically significant reduction of cortisol levels, PSS scale scores, and HAM-A scale scores. In terms of mechanism, according to a systematic review of human trials, among many different supplements, Ashwagandha has the most profound effect on the hypothalamic-pituitary-adrenal (HPA) axis. This effect on the HPA axis — a main regulator of the stress response — is evident through lowered morning cortisol levels following Ashwagandha supplementation.

Safety: A recent systematic review included 30 clinical trials documenting safety of a wide range of Ashwagandha supplementation protocols. None of those studies reported any serious adverse events or changes in vital signs, haematological or biochemical parameters. Most reported no adverse events at all; others reported transient adverse events of mild to moderate severity, with somnolence, giddiness, drowsiness, epigastric discomfort, and vertigo as the most common.

Evidence Strength: The evidence base for Ashwagandha's effects on stress, anxiety, and related constructs of emotional resilience is among the strongest for any botanical adaptogen, with multiple well-designed double-blind RCTs and at least one comprehensive meta-analysis supporting its efficacy. Sample sizes in individual trials remain modest, and most studies are short-term (4–13 weeks).

6.2 Rhodiola rosea

Traditional Use: Rhodiola rosea L. has a long history of use in traditional medicine to stimulate the nervous system, treat stress-induced fatigue and depression, enhance physical performance and work productivity, and treat gastrointestinal ailments and impotence. Rhodiola rosea has a well-established use in the traditional medicinal systems of the Nordic countries, Eastern Europe, and Asia, with a reputation for enhancing mental and physical performance and decreasing symptoms of fatigue.

Scientific Evidence — Clinical Studies: The clearest indication for Rhodiola rosea extract administration is the management of asthenic conditions, including a decline in work performance due to physical or intellectual strain, mental and physical fatigue, sleep disturbances, poor appetite, irritability, hypertension, and headaches. The extract from the rhizomes of R. rosea acts as an adaptogen that aims to increase the body's resistance to imposed stressors and has a normalizing effect independent of the nature — whether environmental or emotional — of the stress signal. The plant's dual actions of cognitive stimulation and emotional calming create benefits for both immediate cognitive and memory performance, as well as for long-term preservation of brain functions.

A double-blind, placebo-controlled, crossover study examined the effect of chronic administration of 170 mg of standardized Rhodiola rosea rhizome extract on aspects of mental performance and fatigue in 56 healthy male and female physicians on night duty for 14 days. Total mental performance was measured by calculating a Fatigue Index reflecting outcomes of complex perceptive and cognitive cerebral functions, such as associative thinking, attention capacity, speed of visual and auditory perception, and short-term memory. Additionally, one multicenter, open-label, exploratory clinical trial aimed to explore clinical outcomes in burnout patients treated with Rhodiola rosea.

Regulatory Standing: This is the main adaptogen given the indication 'stress' by the European Medicines Agency (EMA).

Evidence Strength: Evidence is encouraging, with multiple clinical trials supporting Rhodiola's effects on fatigue, mental performance under stress, and stress resilience. However, many trials are small, and trial heterogeneity limits meta-analytic conclusions. The EMA's positive opinion on its traditional-use monograph reflects the accumulated trial data alongside its historical use record.

6.3 Lavender (Lavandula angustifolia)

Traditional Use: Lavender has been employed for centuries across European herbal traditions as a nervine — a preparation used to calm the nervous system and relieve anxiety, tension, and sleep disturbance. It is typically prepared as a tisane, essential oil for aromatherapy, or topical application.

Scientific Evidence: Lavender provides calming effects through its essential oils, influencing the limbic system and reducing anxiety symptoms. Oral preparations of lavender essential oil (such as the European-marketed product Silexan) have been evaluated in placebo-controlled RCTs for generalized anxiety disorder, showing significant reductions in anxiety scores. Evidence for aromatherapy-based lavender in clinical anxiety is more limited and based on smaller, shorter trials.

Evidence Strength: Evidence for oral lavender preparations in anxiety disorders is moderate-to-good, supported by several RCTs. Evidence for aromatherapy applications and broader emotional resilience outcomes in healthy populations is preliminary.

6.4 Lemon Balm (Melissa officinalis)

Traditional Use: Lemon balm has been used since antiquity in European herbal medicine — documented by physicians of ancient Greece and subsequently by medieval herbalists — as a calming herb for anxiety, nervous tension, and sleep difficulties. Preparations include dried leaf infusions and hydroalcoholic extracts.

Scientific Evidence: Chamomile and Lemon Balm show promise in reducing anxiety and improving cognitive function through their active compounds. Clinical trials in stressed healthy adults have suggested reductions in self-rated anxiety and improvements in mood at doses in the range of 300–600 mg of leaf extract. However, the number of well-powered trials remains small, and evidence is preliminary. Proposed mechanisms include GABA-A receptor modulation via rosmarinic acid.

Evidence Strength: Preliminary. Small sample sizes and varied outcome measures limit conclusions. Traditional use in European herbal systems is well documented; however, clinical evidence for emotionally resilience-relevant outcomes in healthy populations remains insufficient to draw firm conclusions.

6.5 Passionflower (Passiflora incarnata)

Traditional Use: Passionflower was used by indigenous peoples of the Americas for sedation and anxiety relief, and was subsequently adopted into European botanical medicine in the 19th century as a calming nervine. It is typically prepared as a tea or tincture.

Scientific Evidence: Passionflower is effective in regulating GABA levels and serotonin pathways, aiding in anxiety reduction and improved sleep. A small number of RCTs have compared passionflower to benzodiazepine drugs for preoperative anxiety and generalized anxiety, with some showing comparable short-term anxiolytic effects. Evidence in relation to emotional resilience specifically is limited to these anxiety-adjacent outcomes.

Evidence Strength: Preliminary to moderate for acute anxiolysis; evidence specific to emotional resilience as a construct is very limited.

6.6 Chamomile (Matricaria chamomilla)

Traditional Use: Chamomile has one of the longest documented histories in Western herbalism, used by ancient Egyptians, Greeks, and Romans for calming and anti-inflammatory purposes. The dried flowerhead infusion remains among the most widely consumed herbal teas globally.

Scientific Evidence: Chamomile shows promise in reducing anxiety and improving cognitive function through its active compounds. Multiple RCTs have examined standardized chamomile extract for generalized anxiety disorder, with results showing statistically significant reductions in anxiety scores versus placebo. One study followed participants over 26 weeks, finding that chamomile extract significantly reduced rates of relapse in remitted GAD patients relative to placebo. Evidence for broader emotional resilience outcomes in non-clinical populations remains limited.

Evidence Strength: Moderate for GAD-spectrum anxiety outcomes in clinical populations; preliminary for broader resilience applications.

6.7 Valerian (Valeriana officinalis)

Traditional Use: Valerian root has been used since at least ancient Greek medicine as a sedative and anxiolytic, described by Hippocrates and Dioscorides for its calming properties. It continues to be used across European herbal traditions, typically as a dried root decoction, tincture, or standardized extract.

Scientific Evidence: Valerian root shows efficacy in enhancing GABAergic activity, reducing anxiety, and improving sleep without significant drowsiness. Multiple RCTs have investigated valerian for sleep quality and anxiety, with inconsistent but frequently positive results for sleep-onset latency and subjective sleep quality. Evidence for anxiety and resilience outcomes is less consistent. No large-scale, well-powered definitive trial has yet been completed.

Evidence Strength: Moderate for sleep quality; preliminary and inconsistent for anxiety and stress resilience. Methodological heterogeneity across trials impedes firm conclusions.

7. The Gut Microbiome and Emotional Resilience

Key commensals with well-described beneficial effects include Faecalibacterium prausnitzii (a major butyrate producer with anti-inflammatory activity), Akkermansia muciniphila (which supports mucus-layer integrity and metabolic homeostasis), Lactobacillus rhamnosus GG and Lactobacillus plantarum PS128 (psychobiotic strains linked to improvements in stress, mood, and performance), and Clostridium butyricum (butyrate-mediated neuroprotection).

While mostly observational, mounting data from randomized controlled trials support the idea that dietary modification can improve mental health outcomes by altering gut microbial composition and activity. The efficacy of supplements and probiotics in mood outcomes is, however, conflicting. Overall, findings suggest that dietary modifications are feasible and beneficial in mild cases of anxiety and depression.

Animal research has illuminated one pathway by which microbiome disruption may erode emotional resilience: imbalances of the microbiota-gut-brain axis induced by consuming a magnesium-deficient diet may contribute to the development of depressive-like behaviour. This finding underscores the interplay between dietary nutrient adequacy, microbiome composition, and mood-related outcomes.

8. Dietary Patterns and Emotional Resilience

8.1 The Mediterranean Diet

Growing evidence has linked both the onset and symptoms of various mental disorders to lifestyle factors such as diet, exercise, and sleep. The link between diet and mental health, in particular in depressive disorders, has gained interest in recent years.

In Spanish samples, higher Mediterranean diet adherence correlated significantly with better physical functioning, vitality, emotional role, and mental health during the second trimester. Higher Mediterranean diet adherence has also been associated with improved health-related quality of life, particularly in the domains of emotional role functioning, mental health, and overall health perception.

A systematic review of 23 reports found that Mediterranean diet adherence was associated with multiple sleep features, and the joint effect of a healthy diet such as the Mediterranean diet and good sleep quality might be of paramount importance in preventing a large set of chronic non-communicable diseases, especially those concerning the central nervous system.

The Mediterranean diet's mechanism of benefit in this domain is thought to involve multiple converging pathways: high omega-3 intake from fish, anti-inflammatory polyphenols from fruits and vegetables, prebiotic fiber supporting microbiome diversity, and adequate magnesium and B vitamins from whole grains and legumes. These findings suggest that omega-3 fatty acids should not be evaluated in isolation but rather within the context of overall fatty acid balance and dietary pattern.

8.2 Ultra-Processed Foods and Dietary Quality

The inverse of the Mediterranean diet — high consumption of ultra-processed foods, refined sugars, and seed oils rich in omega-6 fatty acids — is consistently associated with poorer mental health outcomes in observational literature. While causality remains difficult to establish definitively in this area due to confounding, the mechanistic rationale (neuroinflammation, gut dysbiosis, nutrient insufficiency) is biologically plausible and increasingly supported by interventional data.

9. Lifestyle Factors

9.1 Physical Activity and BDNF

Emerging evidence indicates that exercise, particularly aerobic activity, elevates BDNF levels in key brain regions such as the hippocampus, fostering neurogenesis and synaptogenesis. These processes contribute to improved emotional regulation, alleviating symptoms of depression and anxiety, while also enhancing cognitive functions such as memory and attention.

Effective therapeutics that mitigate depressive-related symptoms — including physical activity — optimize BDNF in key brain regions, promote neuronal health and recovery of function in MDD-related circuits, and enhance pharmacotherapeutic response. Moderate-intensity endurance exercise (approximately 150 minutes per week at ≥60% VO₂max) enhances stress resilience through adaptive HPA axis activation. Anaerobic exercise forms such as resistance training have also been associated with reduced stress and enhanced resilience.

9.2 Sleep Quality and Circadian Rhythm

Reinforcing the importance of sufficient sleep quality and duration is critical to resilience recovery. Lifestyle factors that may alter the circadian rhythm, such as extreme mental stress, may also contribute to the burden of sleep disorders. Adequate sleep maintains glucocorticoid regulation, emotional memory consolidation, and prefrontal cortical function — all of which are central to emotional resilience.

9.3 Mindfulness, Cognitive-Behavioral Approaches, and Mind-Body Practices

Evidence-based interventions for supporting resilience and HPA axis function include meditative practices, Cognitive-Behavioral Therapy, and Emotional Freedom Techniques. Integrative approaches include patient-centered care, mind-body therapies, dietary and lifestyle interventions, targeted nutraceuticals, and adaptogenic herbs — each aimed at restoring balance and improving stress resilience.

9.4 Social Connection

Social support is consistently identified in the resilience literature as a significant protective factor. It operates in part through neuroendocrine pathways — social engagement modulates oxytocin release and autonomic tone — and in part through psychological pathways including perceived self-efficacy and sense of belonging. Studies have shown that interventions aimed at improving mental health, encouraging physical activity, and fostering social support networks can lead to significant improvements in health-related quality of life.

10. Summary of Evidence Strength

• Ashwagandha (Withania somnifera): Strongest botanical evidence — multiple double-blind RCTs and a meta-analysis demonstrating significant reductions in cortisol, perceived stress, and anxiety. Short-term (4–13 week) data; long-term safety data less robust.
• Omega-3 Fatty Acids (EPA/DHA): Moderate evidence in depression and stress-adjacent outcomes; mixed results across meta-analyses; most consistent effect in EPA-dominant preparations in clinically depressed or high-inflammation subgroups.
• Magnesium: Promising evidence from RCTs for stress, anxiety, and depression-adjacent outcomes; significant meta-analytic signal; complicated by heterogeneity of forms, doses, and populations.
• Rhodiola rosea: Encouraging clinical evidence for fatigue and stress resilience; EMA-recognized traditional use with stress indication; evidence base smaller and more heterogeneous than ashwagandha.
• Mediterranean Dietary Pattern: Consistently supported by observational data and mechanistic plausibility; RCT-level evidence for mood outcomes increasingly available but not yet definitive for resilience specifically.
• Gut Microbiome / Probiotics: Mechanistically compelling; human RCT data for mood outcomes conflicting; specific strain-level evidence emerging but not yet mature for resilience-specific recommendations.
• Lavender, Chamomile, Lemon Balm, Valerian, Passionflower: Preliminary to moderate for anxiety and sleep outcomes; most evidence is in clinical populations with diagnosed conditions rather than in healthy individuals specifically targeting resilience.
• B Vitamins (especially B6, B9, B12): Epidemiological associations well-documented; RCT evidence for resilience-specific outcomes limited; strongest evidence in deficient or at-risk populations.
• Exercise and Sleep: Robust across study designs for improving emotional regulation, BDNF, HPA axis regulation, and resilience-relevant outcomes; these are among the best-evidenced lifestyle factors.

References

• PMC4776579 — Resilience: A psychobiological construct for psychiatric disorders (Indian Journal of Psychiatry, 2016)
• PMC10394620 — Conceptualizing psychological resilience through resting-state functional MRI: a systematic review
• PMC7527537 — The Underlying Mechanisms of Psychological Resilience on Emotional Experience: Attention-Bias or Emotion Disengagement (Frontiers in Psychology, 2020)
• PMC10103153 — The (Neuro)-Science Behind Resilience: A Focus on Stress and Reward
• PMC6717018 — Neurobiology of Resilience: Interface Between Mind and Body
• PMC4009413 — Contingency-based emotional resilience: effort-based reward training and flexible coping (Frontiers in Behavioral Neuroscience, 2014)
• American Journal of Medicine — An Integrative Approach to HPA Axis Dysfunction: From Recognition to Recovery (2025)
• PMC4013121 — Role of Omega-3 Fatty Acids in the Treatment of Depressive Disorders: A Comprehensive Meta-Analysis of Randomized Clinical Trials
• MDPI — Omega-3 Fatty Acids and Mood Disorders: A Critical Narrative Review (2026)
• PMC3573577 — A Prospective, Randomized Double-Blind, Placebo-Controlled Study of Safety and Efficacy of Ashwagandha Root in Reducing Stress and Anxiety in Adults
• PMC8762185 — Effects of Withania somnifera (Ashwagandha) on Stress and Stress-Related Neuropsychiatric Disorders
• PMC11800443 — Withania somnifera (Ashwagandha) supplementation: a review of its mechanisms, health benefits, and role in sports performance
• PubMed 32021735 — Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-blind, Randomized, Placebo-controlled Clinical Study
• PMC12242034 — Effects of Ashwagandha Supplements on Cortisol, Stress, and Anxiety Levels in Adults: A Systematic Review and Meta-Analysis
• PMC9228580 — The Effectiveness of Rhodiola rosea L. Preparations in Alleviating Various Aspects of Life-Stress Symptoms (Molecules, 2022)
• PMC5370380 — Multicenter, open-label, exploratory clinical trial with Rhodiola rosea extract in patients suffering from burnout symptoms
• PMC10783196 — Magnesium supplementation beneficially affects depression in adults with depressive disorder: a systematic review and meta-analysis
• MDPI Nutrients — The Effects of Magnesium Supplementation on Subjective Anxiety and Stress: A Systematic Review (2017)
• PMC6298677 — Superiority of magnesium and vitamin B6 over magnesium alone on severe stress in healthy adults with low magnesemia
• PMC12609437 — The Gut Microbiome and Its Impact on Mood and Decision-Making: A Mechanistic and Therapeutic Review
• PubMed 41026445 — Food and Mood: Current Evidence on Mental Health and the Microbiota-Gut-Brain Axis
• PubMed 25690713 — Dietary magnesium deficiency alters gut microbiota and leads to depressive-like behaviour (Acta Neuropsychiatrica, 2015)
• Nutrition Research Reviews — Effect of Mediterranean diet on mental health outcomes: a systematic review (2025)
• PMC10821402 — Mediterranean Diet and Sleep Features: A Systematic Review of Current Evidence
• PMC5591905 — Brain-Derived Neurotrophic Factor, Depression, and Physical Activity: Making the Neuroplastic Connection
• PMC11853410 — Brain-Derived Neurotrophic Factor (BDNF) as a Marker of Physical Exercise or Activity Effectiveness: A Scoping Review (2025)
• PMC10030936 — Exercise improves depression through positive modulation of BDNF: A review based on 100 manuscripts over 20 years
• PMC11819740 — Mediterranean Diet and Quality of Life in Adults: A Systematic Review (2025)